Global Finance Changes
0
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes Global Finance Changes
  • Finance
  • Investing
  • Stocks
  • Politics
  • Latest news
Global Finance Changes > Investing > RAD receives IND approval from US FDA for Betabart (RV-01)
Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

July 28, 2025

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

0 Shares
Share on Facebook Share on Twitter Share on Pinterest Share on Email
admin July 28, 2025
Previous Article Maiden Drill Program Commences at Oasis Uranium Project
Next Article GTI Energy

You Might Also Enjoy

Uranium Energy’s Sweetwater Project Fast-Tracked Under Trump Initiative

August 7, 2025
READ MORE

First Quantum Secures US$1 Billion in Gold Stream Deal with Royal Gold

August 7, 2025
READ MORE

Productivity Commission Says Trump’s Tariffs Will “Redirect” Others to Australia

August 7, 2025
READ MORE

NextSource Pens Graphite Deal with Mitsubishi​ as US Tightens Grip on Sector

August 7, 2025
READ MORE
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.


    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions
    Copyright © 2025 globalfinancechanges.com | All Rights Reserved

    Our website uses cookies to improve your experience. Learn more about: Cookie Policy

    Accept